| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 165.22B | 130.50B | 60.92B | 26.97B | 26.91B | 16.68B |
| Gross Profit | 115.40B | 97.86B | 44.30B | 15.36B | 17.48B | 10.40B |
| EBITDA | 99.70B | 86.14B | 35.58B | 5.99B | 11.35B | 5.69B |
| Net Income | 86.60B | 72.88B | 29.76B | 4.37B | 9.75B | 4.33B |
Balance Sheet | ||||||
| Total Assets | 140.74B | 111.60B | 65.73B | 41.18B | 44.19B | 28.79B |
| Cash, Cash Equivalents and Short-Term Investments | 56.79B | 43.21B | 25.98B | 13.30B | 21.21B | 11.56B |
| Total Debt | 10.60B | 10.27B | 11.06B | 12.03B | 11.83B | 7.72B |
| Total Liabilities | 40.61B | 32.27B | 22.75B | 19.08B | 17.57B | 11.90B |
| Stockholders Equity | 100.13B | 79.33B | 42.98B | 22.10B | 26.61B | 16.89B |
Cash Flow | ||||||
| Free Cash Flow | 72.02B | 60.85B | 27.02B | 3.81B | 8.13B | 4.69B |
| Operating Cash Flow | 77.03B | 64.09B | 28.09B | 5.64B | 9.11B | 5.82B |
| Investing Cash Flow | -23.89B | -20.42B | -10.57B | 7.38B | -9.83B | -19.68B |
| Financing Cash Flow | -50.08B | -42.36B | -13.63B | -11.62B | 1.86B | 3.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $1.25T | 30.18 | 34.89% | 1.00% | 39.73% | ― | |
81 Outperform | $4.38T | 51.85 | 109.42% | 0.02% | 71.55% | 64.54% | |
81 Outperform | $385.87B | 38.78 | 51.72% | 0.65% | 24.91% | 39.95% | |
79 Outperform | $1.61T | 87.96 | 27.08% | 0.69% | 28.01% | 235.66% | |
72 Outperform | $373.63B | 135.26 | 4.70% | ― | 27.17% | 108.67% | |
72 Outperform | $155.20B | 31.42 | 29.60% | 3.16% | 9.90% | 1.82% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |